Participants were adults aged 18-75 years with a BMI ≥30 or ≥27.5 kg/m2 with the presence of obesity-related comorbidities who initiated a weight management program involving semaglutide or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback